C57BL/6J-Ace2^{em1(ACE2)Synbl}/J

Stock number: 036899
Product name: hACE2-BL6
Research areas: Developmental Biology Research, Immunology, Inflammation and Autoimmunity Research, Internal/Organ Research, Mouse/Human Gene Homologs, Research Tools, Virology Research

Description

Human ACE2 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 2) expression replaces that of the endogenous, X-linked mouse Ace2 gene in these CRISPR/Cas9-generated hACE2-BL6 knock-in/knock-out mice that are useful in studies of viral infection.

Detailed description

Human ACE2 is the receptor used for cellular entry by several coronaviruses, including severe acute respiratory syndrome coronavirus-1 (SARS-CoV), severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2; 2019 novel coronavirus) and HCoV-NL63.

Human ACE2 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 2) expression replaces that of the endogenous, X-linked mouse Ace2 gene in these CRISPR/Cas9-generated hACE2-BL6 knock-in/knock-out mice that are useful in studies of viral infection.

This strain has not yet been described in a publication (April, 2022). Please see the reference section below for updates.

Please note, these mice should be handled in a manner consistent with CDC/ABSA/WHO guidelines for prevention of human infection with the SARS-CoV-2 virus. Proper PPE and handling methods should be used at all times when working with these mice. Additional important guidelines for using SARS-CoV-2 susceptible mouse lines.

Development

Enhanced specificity eSpCas9 and gRNA Ace2-cRNA_32 (protospacer sequence 5’-AAGGCTGAGAAGGAGCCAGG-3’) were used to introduce the following 13 bp downstream of the mouse Ace2 start codon in exon 2:

• Mouse Signal Peptide: signal peptide coding sequence (translation produces amino acid sequence Ace2 WLLLSLVAVTTA) in-frame with first 5 amino acids of mouse Ace2
• hACE2 CDS: human ACE2 cDNA coding sequence with SV40 intron inserted for enhanced expression
• hACE2 3’UTR: 872 bp human ACE2 3’UTR
• hACE2 3’: 100 bp human intergenic sequence immediately 3’ of ACE2 polyadenylation region
• Ace2-gRNA32 Cassette: “Active genetics” cassette comprised of a mouse U6 promoter-driven Ace2-gRNA32 guide RNA with 2xPolIII terminator, all in reverse orientation relative to Ace2
• Splice-Trap FRT Cassette: splice acceptor and SV40 polyadenylation sequence followed by a Flp Recombinase Target (FRT) site and 3-frame ATG short open reading frames. This cassette is designed to trap and truncate any mouse Ace2 isoforms that may splice past the hACE2 cassette. The FRT site would have allowed Flp-mediated collapse of targeted tandem integration events if required.

This strain was created and maintained on a C57BL/6J genetic background. The donating laboratory verified the correct integration and verified the lack of off-target backbone integration.

Upon arrival at The Jackson Laboratory, sperm was cryopreserved. Cryorecovery/live colony development will involve C57BL/6J (Stock No. 000664). (April, 2022)

Allele

Symbol: Ace2^{em1(ACE2)Synbl}
Name: endonuclease-mediated mutation 1, Synbal
MGI accession ID: MGI:7261373
Generation method: Endonuclease-mediated
Attributes: Null/Knockout; Inserted expressed sequence; Humanized sequence
Marker symbol: Ace2
Marker name: angiotensin I converting enzyme (peptidyl-dipeptidase A) 2
Marker synonyms: 2010305L05Rik; ACEH
Chromosome: X
Strain of origin: C57BL/6J
Molecular note: Enhanced specificity eSpCas9 and gRNA Ace2-cRNA_32 (protospacer sequence 5'-AAGGCTGAGAAGGAGCCAGG-3') are used to introduce the following sequence 13 bp downstream of the mouse Ace2 start codon in exon 2: signal peptide coding sequence (translation produces amino acid sequence Ace2 WLLLSLVAVTTA) in-frame with first 5 amino acids of mouse Ace2, human ACE2 cDNA coding sequence with SV40 intron inserted for enhanced expression, 872 bp human ACE2 3' UTR, 100 bp human intergenic sequence immediately 3' of ACE2 polyadenylation region, cassette comprised of a mouse U6 promoter-driven Ace2-gRNA32 guide RNA with 2xPolIII terminator, all in reverse orientation relative to Ace2, splice acceptor and SV40 polyadenylation sequence followed by a Flp Recombinase Target (FRT) site and 3-frame ATG short open reading frames. This cassette is designed to trap and truncate any mouse Ace2 isoforms that may splice past the hACE2 cassette. The FRT site allows Flp-mediated collapse of targeted tandem integration events if required.